FBIO
Fortress Biotech IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$72.13M
P/E Ratio
—
EPS
$-0.07
Beta
1.45
52W High
$4.53
52W Low
$1.60
50-Day MA
$2.88
200-Day MA
$2.90
Dividend Yield
—
Profit Margin
10.80%
Forward P/E
3.73
PEG Ratio
-0.10
About Fortress Biotech Inc
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $63.26M |
| Gross Profit (TTM) | $30.44M |
| EBITDA | $-65.56M |
| Operating Margin | -29.80% |
| Return on Equity | -108.70% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $2.27 |
| Book Value | $1.59 |
| Price-to-Book | 1.45 |
| Price-to-Sales (TTM) | 1.14 |
| EV/Revenue | 1.06 |
| EV/EBITDA | -0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 6.30% |
| Shares Outstanding | $32.20M |
| Float | $22.15M |
| % Insiders | 22.69% |
| % Institutions | 18.32% |
Historical Volatility
HV 10-Day
38.16%
HV 20-Day
62.59%
HV 30-Day
56.43%
HV 60-Day
62.87%
HV Rank
39.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($10.75 target)
2
BuyData last updated: 4/29/2026